Annual report 2022

— Financial reporting — Financial statements of medmix Ltd — Statement of changes in equity of medmix Ltd

Statement of changes in equity of medmix Ltd

thousands of CHF

 

Share capital

 

Legal reserves

 

Reserves from capital contribution

 

Free reserves

 

Retained earnings

 

Net income

 

Treasury shares

 

Total

Equity as of September 20, 2021

 

 

 

 

 

 

 

 

Spin-off from Sulzer Ltd

 

343

 

50’000

 

 

 

293’951

 

 

 

 

 

 

 

344’294

Capital increase

 

70

 

 

 

294’653

 

 

 

 

 

 

 

 

 

294’723

Net loss for the year

 

 

 

 

 

 

 

 

 

 

 

–498

 

 

 

–498

Change in treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

–6’489

 

–6’489

Equity as of December 31, 2021

 

413

 

50’000

 

294’653

 

293’951

 

 

–498

 

–6’489

 

632’030

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity as of January 1, 2022

 

413

 

50’000

 

294’653

 

293’951

 

 

–498

 

–6’489

 

632’030

Capital increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of free reserves

 

 

 

 

 

 

 

–25’000

 

25’000

 

 

 

 

 

Dividend

 

 

 

 

 

 

 

 

 

–20’457

 

 

 

 

 

–20’457

Allocation of net income

 

 

 

 

 

 

 

 

 

–498

 

498

 

 

 

Net profit for the year

 

 

 

 

 

 

 

 

 

 

 

14’270

 

 

 

14’270

Change in treasury shares

 

 

 

 

 

 

 

 

 

 

 

 

 

–5’981

 

–5’981

Equity as of December 31, 2022

 

413

 

50’000

 

294’653

 

268’951

 

4’045

 

14’270

 

–12’470

 

619’862